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Introduction
•  Myxedema coma is a clinically diagnosed, rare, 
life-threatening condition that is seen in less than 
0.1 % of all cases of hypothyroidism. 
•  It is usually precipitated by metabolic-related 
stressors that overwhelm the body’s compen-
satory responses to hypothyroidism: 
	 n  Infection
	 n  Medication
	 n  Trauma
	 n  Burn
	 n  Bleeding
	 n  Stroke
	 n  Surgery
•  Myxedema coma is 
usually seen in older 
women in the winter 
months.
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Case Description
History
•  D. C. is a 59 years old Caucasian female, without 
 history of hypothyroidism, who presented to the 
 emergency department after her family noted mental 
status changes. 
•  The patient has not seen a physician in decades. 
•  Her husband reported that months prior to admission, 
the patient sustained an injury to her right foot after 
stepping on a broken glass at home. The patient 
 declined to seek medical attention and treated it with 
iodine peroxide. 
•  Over the past couple of months prior to admission,  
she had progressively worsening gait dysfunction 
 secondary to foot pain from the non-healing wound. 
•  She developed non-pitting edema initially of the right 
foot, which evolved to include the bilateral lower 
 extremities.
•  The patient became confined to the couch, requiring 
maximum assistance for ambulation. 
•  Her condition worsened during the week prior to 
 admission with cold intolerance, urinary retention, 
 occasional incontinence, hallucinations, slurred slow 
speech and decreasing level of consciousness, in 
 addition to her chronic complains of fatigue, anorexia, 
hair loss and depression. 
Physical Exam
•  On presentation, the patient had hypothermia, 
 bradycardia, hypotension, myxedematous face, 
 alopecia, ascites and Anasarca. 
•  She had a visible non-healing ulcer involving her  
right foot. 
Hospital course
•  The patient was treated in the medical intensive care 
unit where she required intubation for decreased level 
of consciousness, increased work of breathing, and 
 hypoxia. 
•  She was warmed by an external warming blanket and 
resuscitated with intravenous fluids followed by the 
 addition of multiple vasopressors.
•  Treatment of the profound hypothyroidism started with 
levothyroxine 250 mcg IV bolus initially followed by 100 
mcg PO daily. 
•  She was started on antibiotics for presumptive septic 
shock secondary to MSSA osteomyelitis of right 4th toe 
and underwent open transmetatarsal amputation of the 
toe with excisional debridement of right foot when she 
was stabilized from a hemodynamic stand point. 
outcome
•  The patient made an astonishing recovery during her 
twenty day hospital stay and was discharged to a 
skilled nursing facility for rehabilitation.
Discussion
•  We report the successful treatment of a patient with 
myxedema coma with levothyroxine administered via 
an orogastric tube and supportive care in the medical 
ICU. 
•  Reported cases of Myxedema coma are rare. 
•  Despite aggressive management, mortality rate still 
 approaches 40 %. 
•  Prompt recognition and treatment with thyroid 
 hormone combined with pulmonary and cardio vascular 
support in an intensive care setting is essential for 
 survival. 
Investigational studies
•  Extensive laboratory and radiographic testing revealed 
acute hypercapnic respiratory failure, pancytopenia 
with bandemia, hyponatremia, hypokalemia, hypo-
magnesemia, hyperlipidemia, transaminitis, CHF, 
 pneumonia, cerebral edema, pleural and pericardial 
 effusions, and mesenteric edema. 
•  TSH level was elevated at 96.33 uIU/ml with  
T4 < 0.10 ng/dl. 
